MICROTECH MED-B(02235) LinX continuous glucose monitoring system approved to launch in Brazil.

MICROTECH MED-B (02235) announced that the group's LinX continuous glucose monitoring system has recently received market approval in Brazil, suitable for continuous dynamic blood glucose monitoring in adults and children. The company's LinX continuous glucose monitoring system obtaining market approval in Brazil will greatly strengthen the company's market layout in Latin America, laying a solid foundation for the scale expansion and revenue growth of international business. In the future, the company will continue to focus on the global development of diabetes monitoring, treatment, and management methods, continuously driving technological and product innovation in related fields.